Akero Therapeutics, Inc.

AKRODelisted Dec 9, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001744659

SEC filings (opens in a new tab)

Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Akero Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of AKRO: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	153	1	168	+16
Shares	71.8M	5.59M	73.0M	+6.78M (+10.2%)
Value	$1.68B	$131.1M	$2.09B	+$540.6M (+34.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (32)

Institutions that held Akero Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to AKRO in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,747,790	$164.9M	0.00%
Point72 Asset Management, L.P.	1,303,323	$37.4M	0.13%
Deep Track Capital, LP	689,784	$19.8M	0.63%
Hudson Bay Capital Management LP	155,000	$4.45M	0.03%
HRT Financial LP	98,283	$2.82M	0.01%
Exome Asset Management LLC	77,100	$2.21M	1.50%
Cinctive Capital Management LP	65,307	$1.87M	0.11%
Nomura Holdings Inc	18,858	$541.0K	0.00%
Intech Investment Management LLC	17,107	$490.8K	0.01%
Prelude Capital Management, LLC	16,300	$467.6K	0.04%
Creative Planning	12,937	$371.2K	0.00%
XTX Topco Ltd	10,740	$308.1K	0.02%
Envestnet Asset Management Inc	10,708	$307.2K	0.00%
Caption Management, LLC	10,087	$289.4K	0.03%
Point72 Asia (Singapore) Pte. Ltd.	9,230	$264.8K	0.05%
Corton Capital Inc.	7,571	$217.2K	0.11%
Victory Capital Management Inc	7,370	$211.4K	0.00%
HSBC Holdings PLC	7,265	$207.6K	0.00%
Summit Financial Wealth Advisors, LLC	7,155	$205.3K	0.04%
Acadian Asset Management LLC	4,012	$115.0K	0.00%
Eastern Bank	3,500	$100.4K	0.00%
Aquatic Capital Management LLC	3,200	$91.8K	0.00%
Point72 (DIFC) Ltd	808	$23.2K	0.00%
Catalyst Funds Management Pty Ltd	800	$23.0K	0.01%
Aster Capital Management (DIFC) Ltd	463	$13.3K	0.00%
Sterling Capital Management LLC	207	$5.94K	0.00%
Clear Street Markets LLC	137	$4.00K	0.00%
Bessemer Group Inc	60	$2.00K	0.00%
Northwestern Mutual Wealth Management Co	35	$1.00K	0.00%
Capital Performance Advisors LLP	20	$574	0.00%
Continuum Advisory, LLC	18	$536	0.00%
Ronald Blue Trust, Inc.	13	$305	0.00%

Sold out (16)

Institutions that held Akero Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of AKRO in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Braidwell LP	1,084,400	$25.4M
Octagon Capital Advisors LP	283,372	$6.65M
Sphera Funds Management Ltd.	141,620	$3.32M
Renaissance Technologies LLC	24,100	$565.4K
Walleye Capital LLC	23,707	$556.2K
Atom Investors LP	21,050	$493.8K
Capital Fund Management S.A.	17,619	$413.3K
Deerfield Management Company, L.P. (Series C)	11,867	$278.4K
Principal Financial Group Inc	9,494	$222.7K
Engineers Gate Manager LP	9,270	$217.5K
Verition Fund Management LLC	9,256	$217.1K
Bourgeon Capital Management LLC	8,700	$204.1K
EntryPoint Capital, LLC	4,311	$101.1K
Quarry LP	2,000	$46.9K
Banque Cantonale Vaudoise	1,000	$23.0K
Pacer Advisors, Inc.	688	$16.1K

Not filed for Q3 2024 yet (1)

Institutions that held Akero Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding AKRO in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	5,586,637	$131.1M